Table 2.
Assessment | Measurement Instrument |
---|---|
Primary Outcomes | |
Chemotherapy dosing and completion rates (RDI) | Medical record |
Patient-reported chemotherapy-associated toxicities | NCI PRO CTCAE survey |
Secondary Outcomes | |
Body composition | DXA |
Inflammatory blood markers | Serum blood samples |
Chemotherapy-associated toxicities | Medical record |
Patient-reported chemotherapy-associated toxicities | EORTC CIPN20 questionnaire |